HH vs NSIS-B: Side-by-Side Comparison
Compare H+H International A/S (HH) and Novonesis (Novozymes) A/S (NSIS-B) side by side: market cap DKK 1.67B vs DKK 191.95B. Financials, growth and model signals on Bullrun.
| Metric | HH | NSIS-B |
|---|---|---|
| Company | H+H International A/S | Novonesis (Novozymes) A/S |
| Country / Exchange | Denmark · CO | Denmark · CO |
| Sector | Basic Materials | Basic Materials |
| Industry | Building Materials | Specialty Chemicals |
| Market cap | DKK 1.67B | DKK 191.95B |
| P/E ratio | — | 43.1 |
| Dividend yield | — | 1.57% |
| Valuation model | — | 7.3% overvalued |
| Revenue (FY2025) | DKK 2.74B | EUR 4.16B |
| Revenue growth YoY | -0.1% | +8.5% |
| Net income | DKK -665.00M | EUR 583.60M |
| Gross margin | 22.4% | 53.9% |
| Diluted EPS | -40.30 | 1.25 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.